Improving HPV uptake in school leavers living in areas of high deprivation
NHS England · Awarded
- Buyer
- NHS England
- Status
- Awarded
- Country
- United Kingdom
- Region
- England
- Sector
- Professional Services
- Reference
- FaT-ocds-h6vhtk-06eb9f
- Published
- 2026-10-26
Tender summary
The HPV vaccine remains one of the most effective vaccines, providing long-lasting protection against several strains of the human papillomavirus that is known to cause cervical, vaginal, vulval, anal, penile, and head/neck cancers. A single dose of the vaccine is offered to boys and girls aged 12-13 years old through the School Aged Immunisation Service (SAIS). With the COVID-19 pandemic causing significant disruptions to delivery, resulting in a reduction in overall coverage, uptake rates have failed to recover to pre-pandemic levels. There is increasing evidence that HPV uptake is lower…
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access